{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:06:07Z","timestamp":1789067167402,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implement Sci Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Syringe services programs (SSPs) offer critical, evidence-based services for people who use drugs (PWUD), including infectious disease and overdose prevention. SSPs operate from harm reduction and health equity frameworks, prioritizing non-coercive care and client autonomy; these values foster engagement among a community often stigmatized or discriminated against in traditional healthcare settings. As SSPs increasingly expand their clinical service offerings, they may encounter tensions among their core values, internal or funder-driven pressures for service expansion, and partnerships with external healthcare systems. Accordingly, we undertook a qualitative study to understand how SSP staff uphold core values and practice recipient-centeredness, as defined by the Consolidated Framework for Implementation Research (CFIR), when engaging PWUD in health services within harm reduction settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From May 2023 to February 2024, we conducted qualitative interviews with 41 representatives of 27 SSPs serving diverse U.S. jurisdictions. Guided by the CFIR, trained interviewers used semi-structured interview guides to explore SSPs\u2019 health services delivery models. From interviews, recipient-centeredness emerged as a central theme, leading us to employ thematic and narrative analysis to further explore how SSPs defined and operationalized this construct in their programs\u2019 health-related services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SSP staff consistently emphasized the centrality of core values guiding their services, particularly recipient-centeredness. SSPs operationalized recipient-centeredness through three primary facets: accessibility, consistency, and non-coerciveness. These facets informed direct service delivery and referral processes, enabling programs to build trust and meet clients\u2019 complex needs. To uphold these facets, SSPs implemented low-barrier service access, mobile outreach, client-centered referrals, and predictable service schedules despite dynamic and sometimes unsupportive contexts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study offers a specific operationalization of recipient-centeredness for the unique and understudied setting of SSPs, identifying accessibility, consistency, and non-coerciveness as key facets of this organizational culture. Understanding these facets yields actionable guidance for supporting SSPs in implementing values-driven public health and prevention programming. These findings may also be relevant for other harm reduction and low-barrier care settings seeking to preserve trust, dignity, autonomy, and effectiveness while delivering evidence-based services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>NCT06025435<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43058-026-01051-5","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:35:52Z","timestamp":1785238552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Operationalizing recipient-centeredness: three facets of values-driven care in syringe services programs"],"prefix":"10.1186","volume":"7","author":[{"given":"Elana","family":"Forman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Eger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F.","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby L.","family":"Huffaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrot H.","family":"Lambdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis M.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-1919","authenticated-orcid":false,"given":"Angela","family":"R. Bazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2019.07.030","volume":"73","author":"S Colledge","year":"2019","unstructured":"Colledge S, Peacock A, Leung J, Larney S, Grebely J, Hickman M, et al. The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis. Int J Drug Policy. 2019;73:172\u201384. https:\/\/doi.org\/10.1016\/j.drugpo.2019.07.030.","journal-title":"Int J Drug Policy"},{"key":"1051_CR2","doi-asserted-by":"publisher","unstructured":"Larney S, Leung J, Grebely J, Hickman M, Vickerman P, Peacock A, et al. Global systematic review and ecological analysis of HIV in people who inject drugs: national population sizes and factors associated with HIV prevalence. Int J Drug Policy. 2020;77:102656\u2013. https:\/\/doi.org\/10.1016\/j.drugpo.2019.102656.","DOI":"10.1016\/j.drugpo.2019.102656"},{"issue":"10","key":"1051_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","volume":"26","author":"DJ Smith","year":"2015","unstructured":"Smith DJ, Combellick J, Jordan AE, Hagan H. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): a systematic review and meta-analysis. Int J Drug Policy. 2015;26(10):911\u201321. https:\/\/doi.org\/10.1016\/j.drugpo.2015.07.004.","journal-title":"Int J Drug Policy"},{"issue":"7","key":"1051_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/01.ASW.0000559612.06067.55","volume":"32","author":"B Pieper","year":"2019","unstructured":"Pieper B. Nonviral injection-related injuries in Persons Who inject drugs: skin and soft tissue infection, vascular damage, and wounds. Adv Skin Wound Care. 2019;32(7):301\u201310. https:\/\/doi.org\/10.1097\/01.ASW.0000559612.06067.55.","journal-title":"Adv Skin Wound Care"},{"issue":"1","key":"1051_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12954-023-00809-7","volume":"20","author":"K Claborn","year":"2023","unstructured":"Claborn K, Samora J, McCormick K, Whittfield Q, Courtois F, Lozada K, et al. \u201cWe do it ourselves\u201d: strengths and opportunities for improving the practice of harm reduction. Harm Reduct J. 2023;20(1):70\u201314. https:\/\/doi.org\/10.1186\/s12954-023-00809-7.","journal-title":"Harm Reduct J"},{"issue":"2\u20133","key":"1051_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.10.014","volume":"88","author":"J Ahern","year":"2007","unstructured":"Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depen. 2007;88(2\u20133):188\u201396. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.10.014.","journal-title":"Drug Alcohol Depen"},{"issue":"1","key":"1051_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, Walters SM, Ezell J, Ompad DC. \u201cThey look at us like junkies\u201d: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53\u201359. https:\/\/doi.org\/10.1186\/s12954-020-00399-8.","journal-title":"Harm Reduct J"},{"key":"1051_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depen. 2019;198:80\u201386. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.037.","journal-title":"Drug Alcohol Depen"},{"key":"1051_CR9","doi-asserted-by":"publisher","unstructured":"Broz D, Carnes N, Chapin-Bardales J, Des Jarlais DC, Handanagic S, Jones CM, et al. Syringe services Programs\u2019 role in ending the HIV epidemic in the U.S.: why we Cannot do it without them. Am J Prev Med. 2021;61(Suppl 5):SS118\u201329. https:\/\/doi.org\/10.1016\/j.amepre.2021.05.044.","DOI":"10.1016\/j.amepre.2021.05.044"},{"key":"1051_CR10","unstructured":"National Harm Reduction Coalition. Principles of Harm Reduction. New York: National Harm Reduction Coalition; 2024."},{"key":"1051_CR11","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.14018958","volume-title":"Program and operational Characteristics of syringe services programs-data from the National survey of syringe services programs (anonymized)","author":"BH Lambdin","year":"2023","unstructured":"Lambdin BH, Patel SV, Humphrey JL, Wenger LD, Saunders ME, Strack CN, et al. Program and operational Characteristics of syringe services programs-data from the National survey of syringe services programs (anonymized). RTI International; 2023. https:\/\/doi.org\/10.5281\/zenodo.14018958 [Dataset."},{"key":"1051_CR12","doi-asserted-by":"publisher","unstructured":"Behrends CN, Lu X, Corry GJ, LaKosky P, Prohaska SM, Glick SN, et al. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. Drug Alcohol Depen. 2022;232:109323\u2013. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109323.","DOI":"10.1016\/j.drugalcdep.2022.109323"},{"key":"1051_CR13","doi-asserted-by":"publisher","first-page":"104685","DOI":"10.1016\/j.drugpo.2024.104685","volume":"135","author":"LN Sisson","year":"2025","unstructured":"Sisson LN, Block SJ, Triece T, Martin EM, Owczarzak J, Sherman SG, et al. \u201cIt always needs a higher level of care than what I can provide\u201d: practical, ethical, and administrative tensions arising from the integration of wound care services into syringe service programs in Maryland. Int J Drug Policy. 2025;135:104685. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104685.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1051_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/08897077.2018.1443541","volume":"39","author":"MA Bachhuber","year":"2018","unstructured":"Bachhuber MA, Thompson C, Prybylowski A, Benitez J, Mazzella S, Barclay D. Description and outcomes of a Buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program. Subst Abus. 2018;39(2):167\u201372. https:\/\/doi.org\/10.1080\/08897077.2018.1443541.","journal-title":"Subst Abus"},{"key":"1051_CR15","doi-asserted-by":"publisher","unstructured":"Winetsky D, Burack D, Antoniou P, Garcia B, Gordon P, Scherer M. Psychosocial factors and the Care cascade for hepatitis C treatment colocated at a syringe service program. The J Infect Dis. 2020;222(Supplement_5):S392\u2013400. https:\/\/doi.org\/10.1093\/infdis\/jiaa142.","DOI":"10.1093\/infdis\/jiaa142"},{"key":"1051_CR16","doi-asserted-by":"publisher","unstructured":"Perez-Correa A, Abbas B, Riback L, Ghiroli M, Norton B, Murphy S, et al. Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: design and rationale. Contemp Clin Trials. 2022;114:106674\u2013. https:\/\/doi.org\/10.1016\/j.cct.2021.106674.","DOI":"10.1016\/j.cct.2021.106674"},{"key":"1051_CR17","doi-asserted-by":"publisher","unstructured":"Bartholomew TS, Tookes HE, Serota DP, Behrends CN, Forrest DW, Feaster DJ. Impact of routine opt-out HIV\/HCV screening on testing uptake at a syringe services program: an interrupted time series analysis. Int J Drug Policy. 2020;84:102875\u2013. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102875.","DOI":"10.1016\/j.drugpo.2020.102875"},{"key":"1051_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.dadr.2025.100355","volume":"16","author":"CN Behrends","year":"2025","unstructured":"Behrends CN, Des Jarlais DC, Luhur W, Lu X, Corry GJ, Glick SN, et al. On-site health service delivery models at syringe services programs in the United States: results of a national cross-sectional survey. Drug Alcohol Depend Rep. 2025;16:16. https:\/\/doi.org\/10.1016\/j.dadr.2025.100355.","journal-title":"Drug Alcohol Depend Rep"},{"key":"1051_CR19","doi-asserted-by":"crossref","unstructured":"Forman E, Roth A, Huffaker S, Laurano R, Eger W, Akiba C, et al. The landscape of HIV services delivery in U.S. Syringe services programs: a qualitative exploration of current models and opportunities. The College on Problems of Drug Dependence 86th Annual Scientific Meeting. Montreal, Canada: 2024.","DOI":"10.1016\/j.drugalcdep.2024.112150"},{"key":"1051_CR20","doi-asserted-by":"publisher","unstructured":"Behrends CN, Nugent AV, Des Jarlais DC, Frimpong JA, Perlman DC, Schackman BR. Availability of HIV and HCV on-site testing and treatment at syringe Service programs in the United States. JAIDS J Acquired Immune Deficiency Syndromes. 2018;79(2):e76\u201378. https:\/\/doi.org\/10.1097\/QAI.0000000000001792.","DOI":"10.1097\/QAI.0000000000001792"},{"key":"1051_CR21","doi-asserted-by":"publisher","unstructured":"Corcorran MA, Austin EJ, Behrends CN, Briggs ES, Frost MC, Juarez AM, et al. Syringe service program perspectives on barriers, readiness, and programmatic needs to support rollout of the COVID-19 vaccine. J Addict Med. 2023;17(1):e36\u201341. https:\/\/doi.org\/10.1097\/ADM.0000000000001036.","DOI":"10.1097\/ADM.0000000000001036"},{"issue":"1","key":"1051_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12954-024-00952-9","volume":"21","author":"L de Saxe Zerden","year":"2024","unstructured":"de Saxe Zerden L, Ware OD, Lombardi BN, Lombardi BM. Harm reduction workforce, behavioral health, and service delivery in the USA: a cross-sectional study. Harm Reduct J. 2024;21(1):36\u201312. https:\/\/doi.org\/10.1186\/s12954-024-00952-9.","journal-title":"Harm Reduct J"},{"key":"1051_CR23","doi-asserted-by":"publisher","unstructured":"Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1). https:\/\/doi.org\/10.1186\/s12954-017-0196-4.","DOI":"10.1186\/s12954-017-0196-4"},{"issue":"15","key":"1051_CR24","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1007\/s11606-023-08231-2","volume":"38","author":"Z Lindenfeld","year":"2023","unstructured":"Lindenfeld Z, Hagan H, Chang JE. Exploring barriers and facilitators to integrating a harm reduction approach to substance use in three medical settings. J GEN Intern Med. 2023;38(15):3273\u201382. https:\/\/doi.org\/10.1007\/s11606-023-08231-2.","journal-title":"J GEN Intern Med"},{"issue":"1","key":"1051_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/003335490411900109","volume":"119","author":"D Heller","year":"2004","unstructured":"Heller D, McCoy K, Cunningham C. An invisible barrier to integrating HIV primary care with harm reduction services: philosophical clashes between the harm reduction and medical models. Public Health Rep (1974). 2004;119(1):32\u201339. https:\/\/doi.org\/10.1177\/003335490411900109.","journal-title":"Public Health Rep (1974)"},{"issue":"11","key":"1051_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/10872914251376934","volume":"39","author":"AM Roth","year":"2025","unstructured":"Roth AM, Forman E, Akiba CF, Eger WH, Laurano R, Huffaker SL, et al. HIV services implementation within US syringe services programs: a qualitative exploration. AIDS Patient Care STDs. 2025;39(11):441\u201349. https:\/\/doi.org\/10.1177\/10872914251376934.","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"1051_CR27","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1186\/s12913-024-11691-9","volume":"24","author":"M Plesons","year":"2024","unstructured":"Plesons M, Soto Sugar SE, Chimbaru R, McDonald G, Friedman L, Thompson E, et al. COVID-19 vaccine implementation at a syringe services program: experiences of frontline staff. BMC Health Serv Res. 2024;24(1):1260\u201312. https:\/\/doi.org\/10.1186\/s12913-024-11691-9.","journal-title":"BMC Health Serv Res"},{"key":"1051_CR28","doi-asserted-by":"publisher","first-page":"232595822614206","DOI":"10.1177\/23259582261420655","volume":"25","author":"M Plesons","year":"2026","unstructured":"Plesons M, le Forman E, McDowell EC, Krakower D, Amico KR, Groves AK, et al. Staff perspectives on implementation of long-acting injectable preexposure prophylaxis at a Low-barrier syringe services program in Philadelphia, PA. J Int Assoc Provid AIDS Care. 2026;25:23259582261420655. https:\/\/doi.org\/10.1177\/23259582261420655.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"1051_CR29","doi-asserted-by":"publisher","first-page":"105106","DOI":"10.1016\/j.drugpo.2025.105106","volume":"147","author":"WH Eger","year":"2026","unstructured":"Eger WH, Huffaker SL, Forman E, Smith J, Akiba CF, Laurano R, et al. Integration of safer smoking equipment in U.S. syringe services programs: qualitative insights from program staff. Int J Drug Policy. 2026;147:105106. https:\/\/doi.org\/10.1016\/j.drugpo.2025.105106.","journal-title":"Int J Drug Policy"},{"key":"1051_CR30","unstructured":"CFIR research team - Center for clinical management research. The consolidated framework for implementation research - technical assistance for users of the CFIR framework. 2022 [Available from: https:\/\/cfirguide.org\/."},{"key":"1051_CR31","doi-asserted-by":"publisher","unstructured":"Safaeinili N, Brown-Johnson C, Shaw JG, Mahoney M, Winget M. CFIR simplified: pragmatic application of and adaptations to the consolidated framework for implementation research (CFIR) for evaluation of a patient-centered care transformation within a learning health system. Learn Health Syst. 2020;4(1):e10201\u2013n\/a. https:\/\/doi.org\/10.1002\/lrh2.10201.","DOI":"10.1002\/lrh2.10201"},{"key":"1051_CR32","doi-asserted-by":"publisher","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implementation Sci. 2022;17(1). https:\/\/doi.org\/10.1186\/s13012-022-01245-0.","DOI":"10.1186\/s13012-022-01245-0"},{"issue":"5","key":"1051_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative Data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533\u201344. https:\/\/doi.org\/10.1007\/s10488-013-0528-y.","journal-title":"Adm Policy Ment Health"},{"key":"1051_CR34","unstructured":"U.S. Centers for Disease Control and Prevention [CDC]. HIV Surveillance Special Report: HIV Infection Risk. Prevention, and testing behaviors among persons who inject drugs national HIV behavioral surveillance, 20. 2024 [Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/150464 U.S. Cities, 2022."},{"key":"1051_CR35","unstructured":"North American Syringe Exchange Network (NASEN). The NASEN Directory. 2025 [Available from: https:\/\/nasen.org\/."},{"issue":"8","key":"1051_CR36","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s10461-018-02387-3","volume":"23","author":"JM Simoni","year":"2019","unstructured":"Simoni JM, Beima-Sofie K, Amico KR, Hosek SG, Johnson MO, Mensch BS. Debrief reports to expedite the impact of qualitative research: do they accurately capture data from in-depth interviews? AIDS Behav. 2019;23(8):2185\u201389. https:\/\/doi.org\/10.1007\/s10461-018-02387-3.","journal-title":"AIDS Behav"},{"key":"1051_CR37","first-page":"19","volume-title":"Doing reflexive thematic analysis","author":"V Braun","year":"2022","unstructured":"Braun V, Clarke V, Hayfield N, Davey L, Jenkinson E, Bager-Charleson S, et al. Doing reflexive thematic analysis. Cham: Springer International Publishing; 2022. p. 19\u201338."},{"key":"1051_CR38","unstructured":"Dedoose version 9.2.6, cloud application for managing, analyzing, and presenting qualitative and mixed method research data. Los Angeles, CA2025."},{"key":"1051_CR39","volume-title":"Sage Publications p. Narrative methods for the human sciences","author":"CK Riessman","year":"2008","unstructured":"Riessman CK. Sage Publications p. Narrative methods for the human sciences. Thousand Oaks, California: SAGE Publications; 2008."},{"issue":"1","key":"1051_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, Walters SM, Ezell J, Ompad DC. \u201cThey look at us like junkies\u201d: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53. https:\/\/doi.org\/10.1186\/s12954-020-00399-8.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1051_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.JHQ.0000460121.06309.f9","volume":"37","author":"SM Dy","year":"2015","unstructured":"Dy SM, Ashok M, Wines RC, Rojas Smith L. A framework to Guide implementation research for care transitions interventions. J Healthcare Qual (JHQ). 2015;37(1):41\u201354. https:\/\/doi.org\/10.1097\/01.JHQ.0000460121.06309.f9.","journal-title":"J Healthcare Qual (JHQ)"},{"key":"1051_CR42","doi-asserted-by":"publisher","unstructured":"Pauly B. Harm reduction through a social justice lens. Int J Drug Policy. 2008;19(1):4\u201310. https:\/\/doi.org\/10.1016\/j.drugpo.2007.11.005.","DOI":"10.1016\/j.drugpo.2007.11.005"},{"key":"1051_CR43","unstructured":"Institute of Medicine Committee on Quality of Health Care in A. Crossing the Quality chasm: a New health system for the 21st Century. Washington (DC): National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved.; 2001."},{"issue":"4","key":"1051_CR44","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/QAI.0000000000003580","volume":"98","author":"SA Golub","year":"2025","unstructured":"Golub SA, Wolfer C, Chastain CA. Increasing the accessibility and relevance of implementation science for front-line implementers. JAIDS J Acquired Immune Deficiency Syndromes. 2025;98(4):372\u201376. https:\/\/doi.org\/10.1097\/QAI.0000000000003580.","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"1051_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","volume":"10","author":"BJ Powell","year":"2015","unstructured":"Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project. Implementation Sci. 2015;10(1):21. https:\/\/doi.org\/10.1186\/s13012-015-0209-1.","journal-title":"Implementation Sci"},{"issue":"Pt A","key":"1051_CR46","doi-asserted-by":"publisher","first-page":"109124","DOI":"10.1016\/j.drugalcdep.2021.109124","volume":"229","author":"HE Tookes","year":"2021","unstructured":"Tookes HE, Bartholomew TS, Suarez E, Ekowo E, Ginoza M, Forrest DW, et al. Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs. Drug Alcohol Depen. 2021;229(Pt A):109124. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109124.","journal-title":"Drug Alcohol Depen"},{"issue":"1","key":"1051_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12954-022-00721-6","volume":"19","author":"TS Bartholomew","year":"2022","unstructured":"Bartholomew TS, Andraka-Cristou B, Totaram RK, Harris S, Doblecki-Lewis S, Ostrer L, et al. \u201cWe want everything in a one-stop shop\u201d: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for black people who inject drugs. Harm Reduct J. 2022;19(1):133. https:\/\/doi.org\/10.1186\/s12954-022-00721-6.","journal-title":"Harm Reduct J"},{"issue":"4","key":"1051_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/QAI.0000000000003581","volume":"98","author":"SA Golub","year":"2025","unstructured":"Golub SA, Wolfer C, Beacham A, Lane BV, Chastain CA, Meyers KA. Developing a practice-driven taxonomy of implementation strategies for HIV prevention. JAIDS J Acquired Immune Deficiency Syndromes. 2025;98(4):377\u201385. https:\/\/doi.org\/10.1097\/QAI.0000000000003581.","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"1051_CR49","doi-asserted-by":"publisher","unstructured":"Clark KD, Jewell J, Sherman ADF, Balthazar MS, Murray SB, Bosse JD. Lesbian, gay, bisexual, transgender and queer People\u2019s experiences of stigma across the spectrum of inpatient psychiatric Care: a systematic review. Int J Ment Health Nurs. 2025;34(1):e13455. https:\/\/doi.org\/10.1111\/inm.13455.","DOI":"10.1111\/inm.13455"},{"issue":"5","key":"1051_CR50","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/tbm\/ibz200","volume":"10","author":"EK Layland","year":"2020","unstructured":"Layland EK, Carter JA, Perry NS, Cienfuegos-Szalay J, Nelson KM, Bonner CP, et al. A systematic review of stigma in sexual and gender minority health interventions. Transl Behav Med. 2020;10(5):1200\u201310. https:\/\/doi.org\/10.1093\/tbm\/ibz200.","journal-title":"Transl Behav Med"},{"issue":"9","key":"1051_CR51","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1177\/13591053211027652","volume":"27","author":"KM Sileo","year":"2022","unstructured":"Sileo KM, Baldwin A, Huynh TA, Olfers A, Woo J, Greene SL, et al. Assessing LGBTQ+ stigma among healthcare professionals: an application of the health stigma and discrimination framework in a qualitative, community-based participatory research study. J Health Psychol. 2022;27(9):2181\u201396. https:\/\/doi.org\/10.1177\/13591053211027652.","journal-title":"J Health Psychol"},{"issue":"4","key":"1051_CR52","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s11524-022-00641-7","volume":"99","author":"S Rouhani","year":"2022","unstructured":"Rouhani S, Schneider KE, Weicker N, Whaley S, Morris M, Sherman SG. Nimbyism and harm reduction programs: results from Baltimore City: NIMBYism and harm reduction programs. J Urban Health. 2022;99(4):717\u201322. https:\/\/doi.org\/10.1007\/s11524-022-00641-7.","journal-title":"J Urban Health"},{"issue":"4","key":"1051_CR53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2105\/AJPH.2024.307583","volume":"114","author":"SN Facente","year":"2024","unstructured":"Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, et al. Funding and delivery of syringe services programs in the United States, 2022. Am J Public Health. 2024;114(4):435\u201343. https:\/\/doi.org\/10.2105\/AJPH.2024.307583.","journal-title":"Am J Public Health"},{"key":"1051_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugpo.2019.04.006","volume":"70","author":"CM Jones","year":"2019","unstructured":"Jones CM. Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S. Int J Drug Policy. 2019;70:22\u201332. https:\/\/doi.org\/10.1016\/j.drugpo.2019.04.006.","journal-title":"Int J Drug Policy"},{"key":"1051_CR55","doi-asserted-by":"publisher","unstructured":"Pietrantoni D, Barroca C, Lynch S, Byrne J, Ortner M, Kotwani R, et al. A scoping review on the effects of COVID-19 on syringe Service programs in the United States. Cureus. 2023;15(5):e39023. https:\/\/doi.org\/10.7759\/cureus.39023.","DOI":"10.7759\/cureus.39023"},{"key":"1051_CR56","doi-asserted-by":"publisher","first-page":"100421","DOI":"10.1016\/j.ssmqr.2024.100421","volume":"5","author":"CF Akiba","year":"2024","unstructured":"Akiba CF, Smith J, Wenger LD, Morris T, Patel SV, Bluthenthal RN, et al. Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes. SSM - Qualitative Res Health. 2024;5:100421. https:\/\/doi.org\/10.1016\/j.ssmqr.2024.100421.","journal-title":"SSM - Qualitative Res Health"},{"issue":"1","key":"1051_CR57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/003335490411900109","volume":"119","author":"D Heller","year":"2004","unstructured":"Heller D, McCoy K, Cunningham C. An invisible barrier to integrating HIV primary care with harm reduction services: philosophical clashes between the harm reduction and medical models. Public Health Rep. 2004;119(1):32\u201339. https:\/\/doi.org\/10.1177\/003335490411900109.","journal-title":"Public Health Rep"},{"issue":"1","key":"1051_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13012-023-01309-9","volume":"18","author":"WK Wortham","year":"2023","unstructured":"Wortham WK, Rodwin AH, Purtle J, Munson MR, Raghavan R. Revisiting the policy ecology framework for implementation of evidence-based practices in mental health settings. Implementation Sci. 2023;18(1):58. https:\/\/doi.org\/10.1186\/s13012-023-01309-9.","journal-title":"Implementation Sci"},{"key":"1051_CR59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.childyouth.2018.06.008","volume":"91","author":"G Hickey","year":"2018","unstructured":"Hickey G, McGilloway S, O\u2019Brien M, Leckey Y, Devlin M, Donnelly M. Strengthening stakeholder buy-in and engagement for successful exploration and installation: a case study of the development of an area-wide, evidence-based prevention and early intervention strategy. Child Youth Serv Rev. 2018;91:185\u201395. https:\/\/doi.org\/10.1016\/j.childyouth.2018.06.008.","journal-title":"Child Youth Serv Rev"},{"issue":"1","key":"1051_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13012-020-01040-9","volume":"15","author":"SA Birken","year":"2020","unstructured":"Birken SA, Haines ER, Hwang S, Chambers DA, Bunger AC, Nilsen P. Advancing understanding and identifying strategies for sustaining evidence-based practices: a review of reviews. Implementation Sci. 2020;15(1):88. https:\/\/doi.org\/10.1186\/s13012-020-01040-9.","journal-title":"Implementation Sci"}],"container-title":["Implementation Science Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43058-026-01051-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-026-01051-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-026-01051-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:10:14Z","timestamp":1789063814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43058-026-01051-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1186\/s43058-026-01051-5","relation":{},"ISSN":["2662-2211"],"issn-type":[{"value":"2662-2211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of California, San Diego, and Drexel University Institutional Review Boards approved all study protocols and waived the requirement for documentation of informed consent. All study participants provided verbal informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AMR\n                      reports receiving research funds from ViiV Healthcare; however, the company had no role in the conceptualization, design, or conduct of this research. All other authors report no competing interests or conflicts of interest to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"185"}}